Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E FREI

Showing results (151-160 of 428) with videos related to

Pageof 43
Sort By:
IARC Scientific Publications|January 1, 1987
Could N-nitrosamino phosphates be transport forms of activated N-nitrosamines?N Frank, M Wiessler, B L Pool, et al.
Blut|December 1, 1987
Dihydrofolate reductase-activity in brain tissue. Effect of X-irradiationR Ludwig, E Frei, B Kimmig, et al.
General Physiology and Biophysics|May 7, 2002
Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathyM Stiborová, M Hájek, E Frei, et al.
Carcinogenesis|March 1, 1990
Pharmacokinetics of N-nitrodimethylamine and N-nitromethylamine in the ratM Hassel, E Frei, A J Streeter, et al.
IARC Scientific Publications|January 1, 1987
Investigation into the pharmacodynamics of the carcinogen N-nitrodimethylamineM Hassel, E Frei, H R Scherf, et al.
Biochemical Pharmacology|January 5, 2002
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adductsM Stiborová, C A Bieler, M Wiessler, et al.
General Physiology and Biophysics|January 5, 2002
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formationM Stiborová, H H Schmeiser, A Breuer, et al.
Cancer|August 1, 1976
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's diseaseJ J Lokich, E Frei, N Jaffe, et al.
IARC Scientific Publications|January 1, 1984
Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivativesE Frei, B L Pool, W Plesch, et al.
Annals of Surgery|April 1, 1974
Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU)J Lokich, P L Chawla, J Brooks, et al.
Pageof 43

Showing results (151-160 of 428) with videos related to

Sort By:
Pageof 43
IARC Scientific Publications|January 1, 1987
Could N-nitrosamino phosphates be transport forms of activated N-nitrosamines?N Frank, M Wiessler, B L Pool, et al.
Blut|December 1, 1987
Dihydrofolate reductase-activity in brain tissue. Effect of X-irradiationR Ludwig, E Frei, B Kimmig, et al.
General Physiology and Biophysics|May 7, 2002
Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathyM Stiborová, M Hájek, E Frei, et al.
Carcinogenesis|March 1, 1990
Pharmacokinetics of N-nitrodimethylamine and N-nitromethylamine in the ratM Hassel, E Frei, A J Streeter, et al.
IARC Scientific Publications|January 1, 1987
Investigation into the pharmacodynamics of the carcinogen N-nitrodimethylamineM Hassel, E Frei, H R Scherf, et al.
Biochemical Pharmacology|January 5, 2002
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adductsM Stiborová, C A Bieler, M Wiessler, et al.
General Physiology and Biophysics|January 5, 2002
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formationM Stiborová, H H Schmeiser, A Breuer, et al.
Cancer|August 1, 1976
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's diseaseJ J Lokich, E Frei, N Jaffe, et al.
IARC Scientific Publications|January 1, 1984
Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivativesE Frei, B L Pool, W Plesch, et al.
Annals of Surgery|April 1, 1974
Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU)J Lokich, P L Chawla, J Brooks, et al.
Pageof 43